Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,480 | 11,320 | N/A | N/A | -2,430 |
| Depreciation Amortization | 30 | 20 | N/A | N/A | 30 |
| Accounts receivable | -338 | N/A | N/A | N/A | N/A |
| Other Working Capital | N/A | 890 | N/A | N/A | 910 |
| Other Operating Activity | 11,078 | -11,900 | 0 | 0 | 1,710 |
| Operating Cash Flow | $-710 | $330 | $N/A | $N/A | $220 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -210 | -140 | N/A | N/A | -1 |
| Purchase Of Investment | -11,107 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 3,977 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -7,340 | 0 | 0 | -29 |
| Investing Cash Flow | $-7,340 | $-7,480 | $N/A | $N/A | $-30 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 102 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 49,249 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -21 | 43,790 | 0 | 0 | 1,500 |
| Financing Cash Flow | $49,330 | $43,790 | $N/A | $N/A | $1,500 |
| Exchange Rate Effect | -10 | -3 | N/A | N/A | -80 |
| Beginning Cash Position | 1,740 | 1,740 | N/A | N/A | 130 |
| End Cash Position | 43,000 | 38,390 | N/A | N/A | 1,740 |
| Net Cash Flow | $41,260 | $36,640 | $N/A | $N/A | $1,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -710 | 330 | N/A | N/A | 220 |
| Capital Expenditure | -219 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -929 | 330 | 0 | 0 | 220 |